explaned by differences in blood pressure control or other risk factors.
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Is Central Aortic Systolic Pressure Augmentation Solely 
Background:
The augmentaQon of central aortlc systolic pressure. associated with increasing age and cardiovascular mortality, is widely believed to result from pressure wave reflection from the distal aorta or its branches. According to this hypothesis the time to the inflection point (Ti), marking the putative onset of the influence of a reflected pressure wave, would be expected to decrease, and augmentation index (Al) to increase with dtstal progression. This hypothesis has yet to be tested with directly measured pressure waveforms from different sites within the aorta.
Methods:
Aortic pressure waveforms were measured using 2F Millar pressure transducer-tipped catheters in 20 patients (12 male) at 5 pre-determn?d points within the aorta: aortic root, transverse arch, at the levels of the diaphragm, renal arteries and aorhc bifurcation. Waveforms were analysed for Al and Ti. The data were analysed by repeated measures analysis of variance.
Results: Al decreased progressively between the aortic root and bifurcation (P < 0.001) (figure), and Ti increased lp < 0.05). Despite this, as expected there was progressive peripheral amplification of systolic and pulse pressures and a fall in the time to peak pressure (all P < 0.001). There was no difference between genders.
Conclusion:
These data are at variance with the concept that central systolic pressure augmentation results only from pressure wave reflection. Pressure wave propagation phenomena may be important. There is theorebcal benefit in the assessment of central aorhc rather than brachial artery systolic pressure. Optimal blood pressure control in subjects with diabetes mellitus reduces the risk of cardiovascular complications. Thus assessment of central aortic pressure may offer greater benefit, but the method has yet to be evaluated, I" diabetes.
Methods:
Simultaneous invasive central aortic and non-invasive radial waveforms (applanation tonometiy, Milla@ Mikro-ti@ tonometer) were acquired in 19 subjects with type II diabetes and applied to a single-inpuvsingle-output method for the derivation of a transfer function (TF). Individual TFs were averaged to yield a diabetes-specific TF (DTF). Similar data were also acquired from 38 age and sex-matched non-diabetic subjects. A generalised TF (GTF) was applied to the radial data from all subjects, and the DTF to each diabetic subject to yield reconstructed central aortic waveforms. Measured and reconstructed aortic waveforms were analysed for parameters of potential clinical value, including pressures, augmentation index and systolic and diastolic pressure time integrals.
Results: There was no difference between the groups in systolic. or any other directly measured central aoriic pressures. However, the time to inflection was shorter in the diabetics (P < 0.05), with a trend to a higher augmentation index (P < 0.09). There was a significantly greater difference between measured and GTF-derived central systolic pressure in the diabetic (6 f 7 mmHg) (mean * SD) than the non-diabetic group (2 * 8 mmHg) (PC 0.05)). The errors in the other waveform parameters were no different. The use of the DTF reduced the error in derived systolic pressure to 0 * 7 mmHg in the diabetic group. no different than with the GTF in the non-diabetic group. ACE inhibitors were categorized into high (benazepril, quinapril, ramlpril) and low (lisinopril, enalapril. fosinopril, captopril) tissue ACE affinity groups based on previously demonstrated tissue ACE potency.
Results: Among the 851 cases and 1,791 controls who participated, there were 174 high and 566 low affinity tissue ACE inhibitor users. After adjustment, using multivariable logistic regression, for age, sex, race, study source. physical activity, quantity smoked/ day, body mass index, family history of MI, other antihypertensive use, and history of diabetes, hypertension, or hypercholesterolemia, the odds ratio(OR) for Ml among current high affinity ACE Inhibitor users compared with low affinity users was 0.85 (95% Cl: 0.58, 1.24; P=O.39). In addition, increasing tissue ACE potency was not associated with an altered risk of Ml (P for trend = 0.40). Conclusion ACE inhibitor tissue affinity did not appear to affect MI risk in this study.
Therefore, MI protection seen I" clinical trials of specific ACE inhibitors may be generalizable to all agents in this class. Further research is needed to evaluate the effects of dose on drugs with different tissue-ACE affinities and to assess other potential differences among ACE inhibitors. The ECG strain pattern of ST depression and T-wave inversion is a marker for left ventricular hypertrophy (LVH) and adverse prognosis in population studies. However, whether ECG strain IS an independent predictor of cardiovascular (CV) morbidity and mortality in the sening of aggressive antihypertensive therapy is unclear. Methods:
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High Prevalence of Functioning Adrenocortical Lesions in Low Renin Arterial Hypertension
ECGs were examined at study baseline in 6,654 hypertensive patients with EGG LVH by Cornell voltage-duration product and/or Sokolow-Lyon voltage on a screening ECG who were treated in a blinded manner with atenolol-or losartan-based regimens and followed for at least 4 years (mean 4.6+0.9) in the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study. Strain was defined as a downsloping convex ST segment with inverted asymmetrical T-wave opposite to the QRS axis in leads V5 or V6.
